Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia

Neuroscience Letters

Volumn 254, Issue 2, 1998, Pages 121-123

  Lam, Amy G M ^a   Soriano, Marc A ^c   Monn, James A ^b   Schoepp, Darryle D ^b   Lodge, David ^b   McCulloch, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Focal ischaemia; LY354740; MCA occlusion; Metabotropic glutamate receptor; MGluR2; MGluR3; Neuroprotection

Indexed keywords

EGLUMETAD; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BICYCLO COMPOUNDS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0032566556     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00651-X     Document Type: Article

References (15)

1. Battaglia G., Monn J.A., Schoepp D.D. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci. Lett. 229:1997;161-164.
2. Bond A., Monn J.A., Lodge D. A novel orally active Group 2 metabotropic glutamate receptor agonist: LY354740. NeuroReport. 8:1997;1463-1466.
3. Bond A., O'Neill M.J., Hicks C.A., Monn J.A., Lodge D. Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. NeuroReport. 9:1998;1191-1193.
4. Bruno V., Battaglia G., Copani A., Giffard R.G., Raciti G., Raffaele R., Shinozaki H., Nicoletti F. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 7:1995;1906-1913.
5. Bruno, V., Sureda, F.X., Storto, M., Casabona, G., Caruso, A., Knopfel, T., Kuhn, R. and Nicoletti, F., The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling, J. Neurosci., 17:16 (1997) 1891-1897.
6. Buisson A., Choi D.W. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology. 34:1995;1081-1087.
7. Chiamulera C., Albertini P., Valerio E., Reggiani A. Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia. Eur. J. Pharmacol. 216:1996;335-336.
8. Maiese K., Greenburg R., Boccone L., Swiriduk M. Activation of metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats. Neurosci. Lett. 194:1995;173-176.
9. Miyamoto M., Ishida M., Shinozaki H. Aniticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat. Neuroscience. 77(1):1997;131-140.
10. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis and pharmacological characterization of (+)-2-aminobicyclo(3.1.0)hexane-2,5-dicarboxylate: a potent, selective, systemically active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 40:1997;528-537.
11. Nicoletti F., Bruno V., Copani A., Casabona G., Knopfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci. 19(7):1996;267-271.
12. Osborne K.A., Shigeno T., Balarsky A.M., Ford I., McCulloch J., Teasdale G.M., Graham D.I. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J. Neurol. Neurosurg. Psychiatry. 50:1987;402-410.
13. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
14. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerham S.L., Burnett J.P., Belagaje R., Bleakman D., Monn J.A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology. 36(1):1997;1-11.
15. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischemia in the rat. 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.